Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 334

1.

Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontier.

Sangha R, Lara PN Jr, Mack PC, Gandara DR.

Curr Opin Oncol. 2009 Mar;21(2):116-23. doi: 10.1097/CCO.0b013e3283210489. Review.

PMID:
19532012
2.

The role of EGFR inhibitors in nonsmall cell lung cancer.

Ciardiello F, De Vita F, Orditura M, Tortora G.

Curr Opin Oncol. 2004 Mar;16(2):130-5. Review.

PMID:
15075904
3.

Antiangiogenic therapy in nonsmall cell lung cancer.

Gutierrez M, Giaccone G.

Curr Opin Oncol. 2008 Mar;20(2):176-82. doi: 10.1097/CCO.0b013e3282f4e55e. Review.

PMID:
18300767
4.

The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.

Langer CJ, Natale RB.

Semin Oncol. 2005 Dec;32(6 Suppl 10):S23-9. Review.

PMID:
16459176
5.

Antiangiogenic agents in the treatment of nonsmall cell lung cancer: reality and hope.

Ramalingam SS, Belani CP.

Curr Opin Oncol. 2010 Mar;22(2):79-85. doi: 10.1097/CCO.0b013e328335a583. Review.

PMID:
20009926
6.

Inhibition of angiogenesis in the treatment of non-small cell lung cancer.

Keedy VL, Sandler AB.

Cancer Sci. 2007 Dec;98(12):1825-30. Epub 2007 Sep 24. Review.

8.

Antivascular agents for non-small-cell lung cancer: current status and future directions.

Amir E, Mandoky L, Blackhall F, Thatcher N, Klepetko W, Ankersmit HJ, Reza Hoda MA, Ostoros G, Dank M, Dome B.

Expert Opin Investig Drugs. 2009 Nov;18(11):1667-86. doi: 10.1517/13543780903336050. Review.

PMID:
19877762
9.

New antiangiogenetic agents and non-small cell lung cancer.

Gridelli C, Rossi A, Maione P.

Crit Rev Oncol Hematol. 2006 Oct;60(1):76-86. Epub 2006 Jul 13. Review.

PMID:
16843002
10.

Targeted therapies in lung cancer.

Pirker R, Filipits M.

Curr Pharm Des. 2009;15(2):188-206.

PMID:
19149612
11.

Recent developments of targeted therapies in the treatment of non-small cell lung cancer.

Rossi A, Maione P, Colantuoni G, Ferrara C, Rossi E, Guerriero C, Nicolella D, Falanga M, Palazzolo G, Gridelli C.

Curr Drug Discov Technol. 2009 Jun;6(2):91-102. Review.

PMID:
19519336
12.

New targeted therapies for non-small-cell lung cancer: a focus on the epidermal growth factor receptor.

Crawford J.

J Natl Compr Canc Netw. 2003 Jan;1 Suppl 1:S78-86. Review.

PMID:
19795580
13.

Current management of advanced non-small cell lung cancer: targeted therapy.

Isobe T, Herbst RS, Onn A.

Semin Oncol. 2005 Jun;32(3):315-28. Review.

PMID:
15988686
14.

Combined inhibition of the VEGFR and EGFR signaling pathways in the treatment of NSCLC.

Pennell NA, Lynch TJ Jr.

Oncologist. 2009 Apr;14(4):399-411. doi: 10.1634/theoncologist.2008-0276. Epub 2009 Apr 8. Review.

15.

Targeted therapies for non-small cell lung cancer.

Dempke WC, Suto T, Reck M.

Lung Cancer. 2010 Mar;67(3):257-74. doi: 10.1016/j.lungcan.2009.10.012. Epub 2009 Nov 14. Review.

PMID:
19914732
16.

Angiogenesis inhibitors and vascular disrupting agents in non-small cell lung cancer.

Rossi A, Maione P, Ferrara ML, Sacco PC, Schettino C, Bareschino MA, Gridelli C.

Curr Med Chem. 2009;16(30):3919-30. Review.

PMID:
19747132
17.

Clinical relevance of monoclonal antibodies in non small cell lung cancer.

Filipits M.

J BUON. 2009 Sep;14 Suppl 1:S147-52. Review.

PMID:
19785057
18.

Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.

Gridelli C, Massarelli E, Maione P, Rossi A, Herbst RS, Onn A, Ciardiello F.

Cancer. 2004 Oct 15;101(8):1733-44. Review.

19.

The role of new agents in the treatment of non-small cell lung cancer.

Bröker LE, Giaccone G.

Eur J Cancer. 2002 Dec;38(18):2347-61. Review.

PMID:
12460778
20.

Targeted therapy for nonsmall cell lung cancer: focusing on angiogenesis, the epidermal growth factor receptor and multikinase inhibitors.

Kotteas EA, Charpidou AG, Syrigos KN.

Anticancer Drugs. 2010 Feb;21(2):151-68. doi: 10.1097/CAD.0b013e328334da02. Review.

PMID:
20016368
Items per page

Supplemental Content

Write to the Help Desk